Potent covalent irreversible inhibitor of KRAS G12C IBI351 in patients with advanced solid tumors: First-in-human phase I study

作者：Qing Zhou, Nong Yang, Mingfang Zhao, Dingzhi Huang, Jun Zhao, Yan Yu, Ying Yuan, Longhua Sun, Xiaorong Dong, Tongmei Zhang, Qian Chu, Xingya Li, Xiangjiao Meng, Huijuan Wang, Xiang Wang, Dongde Wu, Sheng Hu, Jinlu Shan, Lian Liu, Meili Sun, Zhiye Zhang, Haibo Zhu, Jingjing Huang, Mengna Huang, Lingge Cheng, Sujie Zhang, Hui Zhou, Yi‐Long Wu · 发表于：European Journal of Cancer · 年份：2024 · DOI：10.1016/j.ejca.2024.114337 · 被引用次数：11 · 研究领域：Cancer, Hypoxia, and Metabolism、Click Chemistry and Applications、Protein Kinase Regulation and GTPase Signaling